Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Other Accumulated Expenses (2022 - 2025)

Jin Medical International's Other Accumulated Expenses history spans 4 years, with the latest figure at $13655.0 for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 70.67% year-over-year to $13655.0; the TTM value through Sep 2025 reached $13655.0, up 70.67%, while the annual FY2025 figure was $13655.0, 70.67% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $13655.0 at Jin Medical International, up from $8001.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $24729.0 in Q3 2022 and bottomed at $6665.0 in Q3 2023.
  • The 4-year median for Other Accumulated Expenses is $10828.0 (2024), against an average of $13262.5.
  • The largest annual shift saw Other Accumulated Expenses crashed 73.05% in 2023 before it soared 70.67% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $24729.0 in 2022, then plummeted by 73.05% to $6665.0 in 2023, then rose by 20.05% to $8001.0 in 2024, then soared by 70.67% to $13655.0 in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Other Accumulated Expenses are $13655.0 (Q3 2025), $8001.0 (Q3 2024), and $6665.0 (Q3 2023).